A Meta-Analysis of Efficacy and Safety of PD-1/PD-L1 Inhibitors in Triple-Negative Breast Cancer

OBJECTIVE: To evaluate the efficacy and safety of programmed cell death receptor-1 (PD-1)/programmed cell death-ligand protein-1 (PD-L1) inhibitors in triple-negative breast cancer (TNBC) to provide a treatment basis for TNBC. METHODS: Published case-control studies on PD-1/PD-L1 inhibitors in the t...

Descripción completa

Detalles Bibliográficos
Autor principal: Wang, Chaoyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799355/
https://www.ncbi.nlm.nih.gov/pubmed/35096057
http://dx.doi.org/10.1155/2022/2407211

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799355/
https://www.ncbi.nlm.nih.gov/pubmed/35096057
http://dx.doi.org/10.1155/2022/2407211

Ejemplares similares